MindWalk Holdings CTO to Join AI Drug Discovery & Development Summit

Reuters
2025.11.13 14:00
portai
I'm PortAI, I can summarize articles.

MindWalk Holdings Corp.'s CTO, Dr. Dirk Van Hyfte, will participate in a fireside chat at the AI Drug Discovery & Development Summit 2025 on November 20, 2025. He will discuss the HYFT-powered LensAi platform's role in advancing drug discovery and development. This news was generated by Public Technologies using AI and is for informational purposes only.

MindWalk Holdings Corp. announced that its Chief Technology Officer, Dr. Dirk Van Hyfte, will participate in a fireside chat during the Biology Session at the AI Drug Discovery & Development Summit 2025 on November 20, 2025. Dr. Van Hyfte will discuss how MindWalk’s HYFT-powered LensAi platform is transforming the indexing, connection, and updating of biological knowledge to advance drug discovery and development. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MindWalk Holdings Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251113816303) on November 13, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.